Smad3 is a downstream signaling molecule that mediates TGF-β signaling, and deficiency of Smad3 protects mice from HFD-induced obesity and diabetes through regulation of adipocyte differentiation, and glucose and lipid metabolism [20–23]. This evidence concerns the gene SMAD3 and obesity disorder.